Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Synbiotic Formula (SCV09) in Alzheimer's Disease Patients [NA]
A clinical trial evaluating a synbiotic formula SCV09 in patients with Alzheimer disease is recruiting at the Chinese University of Hong Kon…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab
This clinical trial update notes a prospective cohort study of patients with early Alzheimer's disease being treated with lecanemab, and the…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation [NA]
A completed clinical trial evaluated the feasibility, safety, and tolerability of a virtual reality–based audiovisual stimulation approach i…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Care Ecosystem Consortium Effectiveness Study [NA]
The Care Ecosystem Consortium Effectiveness Study (NCT05669365) conducted by University of California, San Francisco has completed.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Study in Subjects With Mild-to-Moderate Alzheimer's Dementia [Phase 1, Phase 2]
Phase 1/2 clinical trial in mild-to-moderate Alzheimer's disease is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-08-29FDA Approved: LECANEMAB AUTOINJECTOR — Original Application (Eisai Inc.)
The FDA approved the Lecanemab Autoinjector (LECANEMAB-IRMB) in Eisai Inc.'s Original Application, enabling subcutaneous administration of l…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated repurposing bromocriptine to influence beta-amyloid metabolism in Alzheimer's disease, including famili…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) [Phase 2]
Bepranemab (UCB0107) was studied in a Phase 2 trial for efficacy, safety, and tolerability in patients with mild cognitive impairment or mil…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Using SRT to Improve The Drinking Problem Behavior of Elderly People With Dementia During The Care of Day Care [NA]
This clinical trial update describes a study testing SRT to improve problematic drinking behaviors in elderly individuals with Alzheimer's d…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study [NA]
This clinical trial update describes a logistical pilot study evaluating how a multimodal lifestyle intervention affects dementia risk facto…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants [Phase 1]
Novartis is conducting a Phase 1 study to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of NIO752 in participant…
-
FDA approval · 2025-08-28FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Macleods Pharmaceuticals Limited's memantine hydrochloride as a generic product under an Original Application. It is indica…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002) [Phase 1]
Completion of a Phase 1 study evaluating MK-2214 in adults with mild cognitive impairment or mild-to-moderate Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: The Clinical Trial of Low Dose Irradiation for Alzheimer's Disease [Phase 2]
This entry indicates the completion of a Phase 2 clinical trial evaluating low-dose irradiation for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers [Phase 1]
Phase 1 study to assess safety and effects of single and multiple doses of KS101 in healthy volunteers; not yet recruiting.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Comfortage - AD Prevention Strategies [NA]
Clinical trial update for Comfortage - AD Prevention Strategies shows the study is not yet recruiting for Alzheimer disease and related cogn…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Implement and Test Visual Consent Template and Process [NA]
An ongoing clinical trial update describes implementing and testing a visual consent template and process in a study sponsored by Washington…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Falls: A Marker of Preclinical AD
This clinical trial update reports the completion of a study evaluating falls as a potential marker of preclinical Alzheimer's disease.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Autonomic Involvement in Patient With Cognitive Decline [NA]
The document is a clinical trial update describing a study on autonomic involvement in patients with cognitive decline. The trial is current…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support [NA]
A completed Indiana University clinical trial evaluated an education and support program to align preferences among Alzheimer's patients, ca…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Update on enrollment for a study examining the links between diabetes prevention and Alzheimer's disease and dementia outcomes; enrollment i…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: ADRC Clinical Cohort (Alzheimer's Disease)
Clinical trial update shows the ADRC Clinical Cohort for Alzheimer's disease is currently recruiting participants, including those with Alzh…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Environmental Pollutants and Neurological Disorders
A clinical trial at Beijing Tiantan Hospital is evaluating the impact of environmental pollutants on neurological disorders and is currently…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Improved Treatment and Monitoring of Alzheimer's Disease [Phase 2]
This document announces a Phase 2 clinical trial for improved treatment and monitoring of Alzheimer disease that is not yet recruiting.
-
FDA approval · 2025-08-21FDA Approved: LEQEMBI — Supplemental Application (Eisai Inc.)
The FDA approved Eisai’s supplemental application for LEQEMBI (lecanemab). The action updates its approved labeling/indication related to Al…